查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842161

伴侶動物心臟藥物市場規模、佔有率和趨勢分析報告：按產品類型、動物類型、適應症、最終用途、通路、地區和細分市場分類，預測期為2025-2033年

Companion Animal Cardiac Drugs Market Size, Share & Trends Analysis Report By Product (Pimobendan, Furosemide), By Animal Type (Dogs, Cats, Horses), By Indication, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

伴侶動物心臟藥物市場摘要

全球伴侶動物心臟藥物市場預計在 2024 年達到 18.8 億美元，預計到 2033 年將達到 37.3 億美元，2025 年至 2033 年的複合年成長率為 8.13%。

該行業受到幾個關鍵因素的推動，包括寵物心臟相關疾病的日益普遍、寵物的人性化以及寵物醫療保健支出的增加，以及心臟治療技術的不斷創新。

治療方法的進步以及人們對動物心臟健康重要性的日益重視，促使寵物飼主尋求專業的醫療照護。寵物保險的日益普及在推動伴侶動物心臟藥物市場成長方面發揮關鍵作用。像Frank和Trusted Insurance Services Ltd這樣的保險公司提供各種保險計劃，涵蓋多種疾病，包括心臟病、癌症、關節炎、糖尿病、感染疾病和其他慢性病。此類保險減輕了寵物飼主的財務負擔，使他們能夠更有信心地選擇先進的治療方法並專注於長期護理。這種可負擔性和可及性的提高，鼓勵了更早的獸醫干預和持續使用處方藥物，從而擴大了患者群體，並推動了對心臟藥物的持續需求。

此外，市場成長得益於臨床、製藥和公眾意識主導等多面向舉措的共同推動。魁北克省和亞伯達等省份的獸醫學院與私人診所之間的合作，促進了最新心臟病治療通訊協定的推廣應用，使獸醫能夠更有效地診斷和治療心臟病。這直接增加了對心臟病藥物的需求，因為更多伴侶動物能夠及時接受治療。同時，勃林格殷格翰和碩騰加拿大等製藥公司加強了在各省的分銷網路，確保能夠持續獲得先進藥物。藥物供應的增加增強了獸醫開立這些藥物的信心，縮小了治療差距，並改善了慢性心臟疾病的長期管理。

同時，由加拿大愛護動物協會（Humane Canada）和加拿大獸醫協會（CVMA）等機構主導的宣傳宣傳活動在教育飼主了解心臟病早期預警訊號（例如持續咳嗽和體力下降）方面發揮關鍵作用。這些努力促使寵物主人更早就醫並及時開始治療，進一步增加了接受治療的患者數量。臨床通訊協定的改進、強大的藥品分銷體係以及公眾意識的提高，正在推動市場穩步成長，尤其是在ACE抑制劑、利尿劑和BETA阻斷劑關鍵藥物類別方面。

此外，隨著全球對專業動物醫療保健的需求持續成長，監管核准在獸醫循環系統市場的重要性日益凸顯。過去，緩慢且限制重重的核准流程阻礙了創新治療方法和醫療設備的引入，但美國FDA、歐洲藥品管理局（EMA）和印度CDSCO等監管機構正開始採取更精簡的核准方式，以確保患者能夠更快地獲得先進的獸醫解決方案。

例如，2024年5月，FDA核准了多種動物用藥品，其中包括用於治療犬心臟衰竭的藥物。值得注意的是，托拉塞米口服溶液Upcard-CA1獲得了有條件核准，用於治療因粘液瘤性二尖瓣疾病（MMVD）引起的鬱血性心臟衰竭犬的肺水腫。這項核准代表了獸醫循環系統領域的一項重大進展，它拓展了治療選擇，並改善了犬心臟病的治療效果，尤其是在與匹莫苯丹、Spiranolactone和ACE抑制劑等現有療法聯合使用時。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章：伴侶動物心臟病藥物市場趨勢與展望

  • 市場體系展望
    • 母市場
    • 子公司市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 伴侶動物心臟病藥物市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析
    • 法律規範
    • 定價分析
    • 各國主要動物物種數量估計（2024 年）

第4章 伴侶動物心臟藥物市場：依動物類型分類的估算與趨勢分析

  • 細分儀表板
  • 伴侶動物心臟病藥物市場：按動物類型分類的差異分析
  • 伴侶動物心臟病藥物市場規模及趨勢分析（依動物類型分類，2021-2033年）
  • 狗
  • 貓
  • 馬
  • 其他

第5章 伴侶動物心臟藥物市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 伴侶動物心臟病藥物市場：按產品分類的差異分析
  • 伴侶動物心臟病藥物市場規模及產品趨勢分析（2021-2033年）
  • 皮莫本丹
  • Spiranolactone和鹽酸Benazepril那普利
  • Furosemide
  • 其他

第6章：伴侶動物心臟藥物市場：依適應症分類的估算與趨勢分析

  • 細分儀表板
  • 伴侶動物心臟藥物市場：依適應症分析變化
  • 伴侶動物心臟藥物市場規模及趨勢分析（依適應症分類，2021-2033年）
  • 鬱血性心臟衰竭衰竭
  • 心肌病變
  • 心律不整
  • 其他

7. 伴侶動物心臟藥物市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 伴侶動物心臟病藥物市場：按最終用途分類的差異分析
  • 伴侶動物心臟病藥物市場規模及趨勢分析（按最終用途分類），2021-2033年
    • 獸醫醫院和診所
    • 其他

8. 伴侶動物心臟病藥物市場：按分銷管道分類的估算和趨勢分析

  • 細分儀表板
  • 伴侶動物心臟病藥物市場：通路變化分析
  • 伴侶動物心臟病藥物市場規模及趨勢分析（依通路分類，2021-2033年）
    • 醫院/診所藥房
    • 零售
    • 電子商務

9. 伴侶動物心臟病藥物市場：區域估算與趨勢分析

  • 區域儀錶板
  • 2024 年及 2033 年各地區伴侶動物心臟病藥物市場佔有率
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 卡達
    • 阿曼

第10章 競爭格局

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Ceva
    • Merck &Co., Inc.
    • Virbac
    • Zoetis
    • Dechra
    • Bimeda Corporate
    • Biogenesis Bago
    • Vetoquinol SA
  • 策略舉措
  • 其他主要企業名單
Product Code: GVR-4-68040-723-9

Companion Animal Cardiac Drugs Market Summary

The global companion animal cardiac drugs market size was estimated at USD 1.88 billion in 2024 and is projected to reach USD 3.73 billion by 2033, growing at a CAGR of 8.13% from 2025 to 2033. The industry is driven by several key factors, including the rising prevalence of heart-related disorders in pets, increasing pet humanization and expenditure on pet healthcare, and continuous innovation in cardiology treatments.

Advancements in therapies and growing awareness about the importance of cardiac health in animals are encouraging pet owners to pursue specialized care. The rising penetration of pet insurance is playing a crucial role in driving the growth of the companion animal cardiac drugs market. Providers such as Frank and Trusted Insurance Services Ltd offer diverse insurance plans that cover a broad spectrum of illnesses, including heart disease, cancer, arthritis, diabetes, infections, and other chronic conditions. Such coverage eases the financial strain on pet owners, enabling them to opt for advanced treatments and commit to long-term therapies without hesitation. This increased affordability and access encourage earlier veterinary intervention and consistent use of prescribed medications, thereby expanding the treated patient pool and fueling sustained demand for cardiac drugs.

Moreover, the market growth is accelerated by a combination of clinical, pharmaceutical, and awareness-driven initiatives. Collaborations between veterinary schools and private clinics in provinces such as Quebec and Alberta have facilitated the dissemination of updated cardiac care protocols, enabling veterinarians to diagnose and manage heart conditions more effectively. This has expanded the number of companion animals receiving timely treatment, directly increasing the demand for cardiac drugs. In parallel, pharmaceutical firms like Boehringer Ingelheim and Zoetis Canada have strengthened their provincial distribution networks, ensuring consistent availability of advanced medications. Reliable access encourages veterinarians to prescribe therapies with greater confidence, reducing treatment gaps and improving long-term management of chronic cardiac conditions.

At the same time, awareness campaigns led by organizations such as Humane Canada and the Canadian Veterinary Medical Association (CVMA) have played a crucial role in educating pet owners about early warning signs of heart disease, such as persistent coughing or reduced stamina. These initiatives prompt earlier veterinary consultations and timely initiation of treatment, further enlarging the treated patient pool. Collectively, improved clinical protocols, strong drug distribution infrastructure, and greater public awareness are fueling steady market growth, particularly in key drug categories like ACE inhibitors, diuretics, and beta-blockers.

Furthermore, regulatory approval is becoming increasingly important in the veterinary cardiology market as global demand for specialized animal care continues to grow. In the past, slow and restrictive approval processes limited the adoption of innovative treatments and medical devices, but regulatory agencies such as the U.S. FDA, the European Medicines Agency (EMA), and India's CDSCO have started to adopt more facilitative approaches to ensure faster access to advanced veterinary solutions.

For instance, in May 2024, the FDA approved several animal drugs, including therapies for canine heart failure. Notably, UpCard-CA1, a torsemide oral solution, received conditional approval for treating pulmonary edema in dogs with congestive heart failure caused by myxomatous mitral valve disease (MMVD). Used in combination with established therapies such as pimobendan, spironolactone, and ACE inhibitors, this approval represents a significant advancement in veterinary cardiology by expanding treatment options and improving the management of cardiac conditions in dogs.

Global Companion Animal Cardiac Drugs Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal cardiac drugs market report based on animal type, product, indication, end-use, distribution channel, and region.

  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dogs
  • Cats
  • Horses
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Pimobendan
  • Spironolactone and benazepril hydrochloride
  • Furosemide
  • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Congestive Heart Failure
  • Myocardial (Heart Muscle) Disease
  • Arrhythmias
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital/ Clinic Pharmacy
  • Retail
  • E-Commerce
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion animal cardiac drugs market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence Of Cardiac Diseases In Animals
      • 3.2.1.2. Increasing Animal Health Expenditure
      • 3.2.1.3. Rising Surgical Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Companion animal cardiac drugs market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Estimated Animal Population by key species, key countries, 2024

Chapter 4. Companion animal cardiac drugs Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion animal cardiac drugs Market: Animal Type Movement Analysis
  • 4.3. Companion animal cardiac drugs market Size & Trend Analysis, by Animal Type, 2021 to 2033 (USD Million)
  • 4.4. Dogs
    • 4.4.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cats
    • 4.5.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Horses
    • 4.6.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Cardiac Drugs Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion animal cardiac drugs Market: Product Movement Analysis
  • 5.3. Companion animal cardiac drugs market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Pimobendan
    • 5.4.1. Pimobendan Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. spironolactone and benazepril hydrochloride
    • 5.5.1. spironolactone and benazepril hydrochloride Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Furosemide
    • 5.6.1. Furosemide Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Cardiac Drugs Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion animal cardiac drugs Market: Indication Movement Analysis
  • 6.3. Companion animal cardiac drugs market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 6.4. Congestive Heart Failure
    • 6.4.1. Congestive Heart Failure Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Myocardial (Heart Muscle) Disease
    • 6.5.1. Myocardial (Heart Muscle) Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Arrhythmias
    • 6.6.1. Arrhythmias Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion animal cardiac drugs Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion animal cardiac drugs Market: By End Use Movement Analysis
  • 7.3. Companion animal cardiac drugs market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Others
      • 7.3.2.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion animal cardiac drugs Market: By Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Companion animal cardiac drugs Market: By Distribution Channel Movement Analysis
  • 8.3. Companion animal cardiac drugs market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 8.3.1. Hospitals/Clinic pharmacy
      • 8.3.1.1. Hospitals/Clinic pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Retail
      • 8.3.2.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. E-Commerce
      • 8.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Companion animal cardiac drugs Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Companion animal cardiac drugs market Share, By Region, 2024 & 2033, USD Million
  • 9.3. Regional Outlook
  • 9.4. North America
    • 9.4.1. North America Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. U.S. Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Canada Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Mexico Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. UK Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Germany Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. France Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Italy Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Spain Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Denmark Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Competitive Scenario
      • 9.5.8.3. Sweden Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Competitive Scenario
      • 9.5.9.3. Norway Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Japan Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. China Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. India Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Australia Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Competitive Scenario
      • 9.6.6.3. South Korea Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Competitive Scenario
      • 9.6.7.3. Thailand Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Brazil Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Argentina Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competitive Scenario
      • 9.8.2.3. South Africa Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competitive Scenario
      • 9.8.3.3. Saudi Arabia Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competitive Scenario
      • 9.8.4.3. UAE Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competitive Scenario
      • 9.8.5.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.6. Qatar
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Competitive Scenario
      • 9.8.6.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.7. Oman
      • 9.8.7.1. Key Country Dynamics
      • 9.8.7.2. Competitive Scenario
      • 9.8.7.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heap Map Analysis
  • 10.3. Company Profiles
    • 10.3.1. Boehringer Ingelheim International GmbH
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Elanco
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Ceva
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Merck & Co., Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Virbac
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Zoetis
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Dechra
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Bimeda Corporate
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Biogenesis Bago
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Vetoquinol SA
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
  • 10.4. Strategic Initiatives
  • 10.5. List of other Key players

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 Companion Animal Cardiac Drugs Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 4 Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 6 Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 8 North America Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 10 North America Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 North America Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 12 North America Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 North America Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 14 U.S. Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 U.S. Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 17 U.S. Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 18 U.S. Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19 Canada Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Canada Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 22 Canada Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Canada Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 Mexico Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 25 Mexico Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Mexico Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 27 Mexico Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28 Mexico Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 Europe Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 30 Europe Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 31 Europe Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 Europe Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 33 Europe Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Europe Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 35 Germany Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Germany Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 38 Germany Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Germany Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 40 UK Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 41 UK Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 UK Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 43 UK Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 UK Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 France Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 46 France Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 France Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 48 France Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 France Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 50 Italy Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 51 Italy Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 52 Italy Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 53 Italy Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Italy Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 55 Spain Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 56 Spain Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Spain Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 58 Spain Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59 Spain Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 60 Denmark Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 Denmark Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 63 Denmark Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Denmark Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 65 Sweden Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 66 Sweden Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Sweden Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 68 Sweden Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Sweden Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Norway Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 71 Norway Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Norway Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 73 Norway Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Norway Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 81 China Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 82 China Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 83 China Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 84 China Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 China Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 Japan Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 87 Japan Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Japan Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 89 Japan Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 Japan Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 91 India Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 92 India Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 India Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 94 India Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 95 India Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 96 South Korea Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 97 South Korea Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 98 South Korea Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 99 South Korea Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 South Korea Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 101 Australia Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 102 Australia Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 103 Australia Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 104 Australia Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 105 Australia Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 106 Thailand Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 107 Thailand Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 108 Thailand Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 109 Thailand Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 110 Thailand Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 111 Latin America Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 112 Latin America Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 113 Latin America Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Latin America Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 115 Latin America Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 116 Latin America Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 117 Brazil Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 118 Brazil Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 119 Brazil Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 120 Brazil Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Brazil Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 122 Argentina Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 123 Argentina Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 124 Argentina Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 125 Argentina Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 126 Argentina Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 127 MEA Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 128 MEA Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 129 MEA Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 130 MEA Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 131 MEA Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 132 MEA Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 133 South Africa Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 134 South Africa Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 135 South Africa Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 136 South Africa Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 137 South Africa Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 143 UAE Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 144 UAE Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 145 UAE Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 146 UAE Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 147 UAE Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 148 Kuwait Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 153 Qatar Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 154 Qatar Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 155 Qatar Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 156 Qatar Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 157 Qatar Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 158 Oman Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 159 Oman Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 160 Oman Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 161 Oman Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 162 Oman Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 163 Company Overview
  • Table 164 Product Benchmarking
  • Table 165 Financial Performance
  • Table 166 Strategic Initiatives

List of Figures

  • Fig. 1 Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modelling For Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Companion Animal Cardiac Drugs Market Revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Companion Animal Cardiac Drugs Market Snapshot
  • Fig. 11 Companion Animal Cardiac Drugs Market Driver Impact
  • Fig. 12 Companion Animal Cardiac Drugs Market Restraint Impact
  • Fig. 13 Companion Animal Cardiac Drugs Animal Type Key Takeaways (USD Million)
  • Fig. 14 Companion Animal Cardiac Drugs Market: Animal Type, Market Share 2024 & 2033
  • Fig. 15 Dogs Market, 2021 - 2033 (USD Million)
  • Fig. 16 Cats Market, 2021 - 2033 (USD Million)
  • Fig. 17 Horses Market, 2021 - 2033 (USD Million)
  • Fig. 18 Others Market, 2021 - 2033 (USD Million)
  • Fig. 19 Companion Animal Cardiac Drugs Product Key Takeaways (USD Million)
  • Fig. 20 Companion Animal Cardiac Drugs Market: Product, Market Share 2024 & 2033
  • Fig. 21 Pimobendan Market, 2021 - 2033 (USD Million)
  • Fig. 22 Spironolactone And Benazepril Hydrochloride Market, 2021 - 2033 (USD Million)
  • Fig. 23 Furosemide Market, 2021 - 2033 (USD Million)
  • Fig. 24 Others Market, 2021 - 2033 (USD Million)
  • Fig. 25 Companion Animal Cardiac Drugs Indication Key Takeaways (USD Million)
  • Fig. 26 Companion Animal Cardiac Drugs Market: Indication, Market Share 2024 & 2033
  • Fig. 27 Congestive Heart Failure Market, 2021 - 2033 (USD Million)
  • Fig. 28 Myocardial (Heart Muscle) Disease Market, 2021 - 2033 (USD Million)
  • Fig. 29 Arrhythmias Market, 2021 - 2033 (USD Million)
  • Fig. 30 Others Market, 2021 - 2033 (USD Million)
  • Fig. 31 Companion Animal Cardiac Drugs End Use Key Takeaways (USD Million)
  • Fig. 32 Companion Animal Cardiac Drugs Market: End Use, Market Share 2024 & 2033
  • Fig. 33 Veterinary Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • Fig. 34 Others Market, 2021 - 2033 (USD Million)
  • Fig. 35 Companion Animal Cardiac Drugs Market By Distribution Channel: Key Takeaways
  • Fig. 36 Companion Animal Cardiac Drugs Market By Distribution Channel, Market Share, 2024 & 2033
  • Fig. 37 Hospital/ Clinic Pharmacy Market, 2021 - 2033 (USD Million)
  • Fig. 38 Retail Market, 2021 - 2033 (USD Million)
  • Fig. 39 E-Commerce Market, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Market Place: Key Takeaways
  • Fig. 41 Regional Outlook, 2024 & 2033
  • Fig. 42 North America Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 44 Canada Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 47 UK Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 48 Germany Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 49 France Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 50 Italy Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 51 Spain Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 52 Denmark Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 54 Norway Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 55 Asia Pacific Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 56 Japan Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 57 China Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 58 India Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 59 Australia Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 61 Thailand Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 62 Latin America Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 63 Brazil Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 64 Argentina Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 65 MEA Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 66 South Africa Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 67 Saudi Arabia Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 68 UAE Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 69 Kuwait Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 70 Qatar Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 71 Oman Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 72 Market Participant Categorization